9FNN
 
 | | Cryo-EM structure of the c-di-GMP-saturated 'crown'less Bcs macrocomplex for cellulose secretion in E. coli | | Descriptor: | 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one), ADENOSINE-5'-TRIPHOSPHATE, Cell division protein, ... | | Authors: | Anso, I, Krasteva, P.V. | | Deposit date: | 2024-06-10 | | Release date: | 2024-10-16 | | Last modified: | 2024-10-23 | | Method: | ELECTRON MICROSCOPY (2.85 Å) | | Cite: | Structural basis for synthase activation and cellulose modification in the E. coli Type II Bcs secretion system. Nat Commun, 15, 2024
|
|
9FMZ
 
 | | Cryo-EM structure of the c-di-GMP-bound synthase:pEtN transferase complex (BcsA-Bct-G3) from the E. coli cellulose secretion macrocomplex | | Descriptor: | 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one), Cellulose biosynthesis protein BcsG, Cellulose synthase catalytic subunit [UDP-forming], ... | | Authors: | Anso, I, Krasteva, P.V. | | Deposit date: | 2024-06-07 | | Release date: | 2024-10-16 | | Last modified: | 2024-10-23 | | Method: | ELECTRON MICROSCOPY (3.6 Å) | | Cite: | Structural basis for synthase activation and cellulose modification in the E. coli Type II Bcs secretion system. Nat Commun, 15, 2024
|
|
9OG5
 
 | | SARS-COV-2-6P-MUT7 S PROTEIN-DY-III-281 complex 1 RBD up conformation | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein, ... | | Authors: | Chandravanshi, M, Niu, L, Tolbert, W.D, Pazgier, M. | | Deposit date: | 2025-04-30 | | Release date: | 2025-10-01 | | Last modified: | 2025-10-29 | | Method: | ELECTRON MICROSCOPY (3.3 Å) | | Cite: | Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants. J.Virol., 2025
|
|
9F22
 
 | | DARPin eGFP complex DP1 (3G190.24) | | Descriptor: | 1,2-ETHANEDIOL, BROMIDE ION, DARPin DP1, ... | | Authors: | Mittl, P.R, Winkelvoss, D. | | Deposit date: | 2024-04-22 | | Release date: | 2024-10-23 | | Last modified: | 2025-11-12 | | Method: | X-RAY DIFFRACTION (2.2 Å) | | Cite: | Molecular features defining the efficiency of bioPROTACs. Commun Biol, 8, 2025
|
|
9OOK
 
 | |
8VGQ
 
 | |
8QWP
 
 | | Structure of p53 cancer mutant Y236C | | Descriptor: | 1,2-ETHANEDIOL, Cellular tumor antigen p53, L(+)-TARTARIC ACID, ... | | Authors: | Balourdas, D.I, Knapp, S, Joerger, A.C, Structural Genomics Consortium (SGC) | | Deposit date: | 2023-10-19 | | Release date: | 2024-06-19 | | Method: | X-RAY DIFFRACTION (2.1 Å) | | Cite: | Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators. Cell Death Dis, 15, 2024
|
|
8RAK
 
 | |
8CDM
 
 | | Plasmodium falciparum Myosin A full-length, post-rigor state complexed to the inhibitor KNX-002 | | Descriptor: | 1,2-ETHANEDIOL, 1-(4-methoxyphenyl)-~{N}-[(3-thiophen-2-yl-1~{H}-pyrazol-4-yl)methyl]cyclopropan-1-amine, Myosin A tail domain interacting protein, ... | | Authors: | Moussaoui, D, Robblee, J.P, Robert-Paganin, J, Auguin, D, Fisher, F, Fagnant, P.M, MacFarlane, J.E, Mueller-Dieckmann, C, Baum, J, Trybus, K.M, Houdusse, A. | | Deposit date: | 2023-01-31 | | Release date: | 2024-02-21 | | Last modified: | 2024-10-16 | | Method: | X-RAY DIFFRACTION (2.35 Å) | | Cite: | Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design. Nat Commun, 14, 2023
|
|
9NZN
 
 | | Crystal Structure of Kirsten Rat Sarcoma G12C Complexed with GDP and Covalently Bound to an Adduct of (2S)-1-{4-[(7P)-7-(8-ethynyl-7-fluoro-3-hydroxynaphthalen-1-yl)-8-fluoro-2-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}pyrido[4,3-d]pyrimidin-4-yl]piperazin-1-yl}-2-fluoro-3-(1,3-thiazol-2-yl)propan-1-one | | Descriptor: | (2S)-1-{4-[(7P)-7-(8-ethynyl-7-fluoro-3-hydroxynaphthalen-1-yl)-8-fluoro-2-{[(2R,4R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy}pyrido[4,3-d]pyrimidin-4-yl]piperazin-1-yl}-2-fluoro-3-(1,3-thiazol-2-yl)propan-1-one, GUANOSINE-5'-DIPHOSPHATE, Isoform 2B of GTPase KRas, ... | | Authors: | Sheriff, S, Pokross, M, Witmer, M. | | Deposit date: | 2025-04-01 | | Release date: | 2025-11-05 | | Method: | X-RAY DIFFRACTION (1.504 Å) | | Cite: | Novel covalent warhead imparts potent activity against both GDP- and GTP-bound forms of KRAS G12C To be published
|
|
6PMC
 
 | | TRK-A IN COMPLEX WITH LIGAND 1a | | Descriptor: | High affinity nerve growth factor receptor, N-(6-{[(5-chloro-2-methoxyphenyl)carbamoyl]amino}-1,3-benzothiazol-2-yl)benzamide | | Authors: | Subramanian, G, Brown, D.G. | | Deposit date: | 2019-07-01 | | Release date: | 2020-02-26 | | Last modified: | 2024-10-30 | | Method: | X-RAY DIFFRACTION (2.19 Å) | | Cite: | Synthetic inhibitor leads of human tropomyosin receptor kinase A ( h TrkA). Rsc Med Chem, 11, 2020
|
|
8QWM
 
 | | Structure of p53 cancer mutant Y205C | | Descriptor: | 1,2-ETHANEDIOL, Cellular tumor antigen p53, L(+)-TARTARIC ACID, ... | | Authors: | Balourdas, D.I, Knapp, S, Joerger, A.C, Structural Genomics Consortium (SGC) | | Deposit date: | 2023-10-19 | | Release date: | 2024-06-19 | | Method: | X-RAY DIFFRACTION (1.54 Å) | | Cite: | Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators. Cell Death Dis, 15, 2024
|
|
6SIX
 
 | | PaaK family AMP-ligase with ANP | | Descriptor: | 1,2-ETHANEDIOL, AMP-dependent synthetase and ligase, CITRATE ANION, ... | | Authors: | Naismith, J.H, Song, H. | | Deposit date: | 2019-08-12 | | Release date: | 2020-01-15 | | Last modified: | 2024-05-15 | | Method: | X-RAY DIFFRACTION (1.88 Å) | | Cite: | The Biosynthesis of the Benzoxazole in Nataxazole Proceeds via an Unstable Ester and has Synthetic Utility. Angew.Chem.Int.Ed.Engl., 59, 2020
|
|
7T5Z
 
 | | P. aeruginosa LpxA in complex with ligand L8 | | Descriptor: | (4S)-N-(1H-tetrazol-5-yl)-2-[3-(trifluoromethyl)benzene-1-sulfonyl]-1,2,3,4-tetrahydroisoquinoline-4-carboxamide, Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase, DI(HYDROXYETHYL)ETHER | | Authors: | Sacco, M, Chen, Y. | | Deposit date: | 2021-12-13 | | Release date: | 2022-07-06 | | Last modified: | 2023-10-18 | | Method: | X-RAY DIFFRACTION (2.25 Å) | | Cite: | Structure-Based Ligand Design Targeting Pseudomonas aeruginosa LpxA in Lipid A Biosynthesis. Acs Infect Dis., 8, 2022
|
|
6DHM
 
 | | Bovine glutamate dehydrogenase complexed with zinc | | Descriptor: | GLUTAMIC ACID, GUANOSINE-5'-TRIPHOSPHATE, Glutamate dehydrogenase 1, ... | | Authors: | Smith, T.J. | | Deposit date: | 2018-05-20 | | Release date: | 2018-07-25 | | Last modified: | 2024-03-13 | | Method: | X-RAY DIFFRACTION (3 Å) | | Cite: | A novel mechanism of V-type zinc inhibition of glutamate dehydrogenase results from disruption of subunit interactions necessary for efficient catalysis. FEBS J., 278, 2011
|
|
1PJO
 
 | | Crystal Structure of an RNA/DNA hybrid of HIV-1 PPT | | Descriptor: | 5'-D(*CP*TP*TP*TP*TP*CP*TP*TP*TP*G)-3', 5'-R(*CP*AP*AP*AP*GP*AP*AP*AP*AP*G)-3', MAGNESIUM ION | | Authors: | Kopka, M.L, Lavelle, L, Han, G.W, Ng, H.-L, Dickerson, R.E. | | Deposit date: | 2003-06-03 | | Release date: | 2003-12-09 | | Last modified: | 2024-04-03 | | Method: | X-RAY DIFFRACTION (1.1 Å) | | Cite: | An Unusual Sugar Conformation in the Structure of an RNA/DNA
Decamer of the Polypurine Tract May Affect Recognition by RNase H J.Mol.Biol., 334, 2003
|
|
8YIY
 
 | | Cryo-EM structure of human proteasome assembly intermediate preholo-1 | | Descriptor: | Proteasome assembly chaperone 1, Proteasome assembly chaperone 2, Proteasome maturation protein, ... | | Authors: | Han, Y, Han, Q, Tang, Q, Zhang, Y, Liu, K. | | Deposit date: | 2024-02-29 | | Release date: | 2025-01-15 | | Last modified: | 2025-01-22 | | Method: | ELECTRON MICROSCOPY (3.41 Å) | | Cite: | Molecular basis for the stepwise and faithful maturation of the 20 S proteasome. Sci Adv, 11, 2025
|
|
9CD1
 
 | | Crystal structure of the Klebsiella pneumoniae LpxH / JH-LPH-107 complex | | Descriptor: | MANGANESE (II) ION, N-(4-{4-[6-chloro-4-(trifluoromethyl)pyridin-2-yl]piperazine-1-sulfonyl}phenyl)-2-[(methanesulfonyl)(methyl)amino]benzamide, UDP-2,3-diacylglucosamine hydrolase | | Authors: | Cochrane, C.S, Zhou, P. | | Deposit date: | 2024-06-23 | | Release date: | 2025-02-12 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | Design and Evaluation of Pyridinyl Sulfonyl Piperazine LpxH Inhibitors with Potent Antibiotic Activity Against Enterobacterales. Jacs Au, 4, 2024
|
|
8H7X
 
 | | Crystal structure of EGFR T790M/C797S mutant in complex with brigatinib | | Descriptor: | 5-chloro-N~4~-[2-(dimethylphosphoryl)phenyl]-N~2~-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine, Epidermal growth factor receptor | | Authors: | Kukimoto-Niino, M, Shirouzu, M. | | Deposit date: | 2022-10-21 | | Release date: | 2023-10-25 | | Last modified: | 2024-03-06 | | Method: | X-RAY DIFFRACTION (3.404 Å) | | Cite: | A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer. NPJ Precis Oncol, 8, 2024
|
|
8VPQ
 
 | | The structure of LSD1-CoREST-HDAC1 in complex with KBTBD4IPR310delinsTTYML | | Descriptor: | Histone deacetylase 1, INOSITOL HEXAKISPHOSPHATE, Isoform 2 of Kelch repeat and BTB domain-containing protein 4, ... | | Authors: | Xie, X, Liau, B, Zheng, N. | | Deposit date: | 2024-01-16 | | Release date: | 2024-11-27 | | Last modified: | 2025-06-11 | | Method: | ELECTRON MICROSCOPY (3.3 Å) | | Cite: | Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations. Nature, 639, 2025
|
|
9JK1
 
 | | Crystal structure of CDK12/Cyclin K in complex with covalent inhibitor YJZ5118 | | Descriptor: | 1,2-ETHANEDIOL, Cyclin-K, Cyclin-dependent kinase 12, ... | | Authors: | Huang, W.X, Zhang, P.J, Yang, J.Z, Ding, K. | | Deposit date: | 2024-09-14 | | Release date: | 2025-05-07 | | Method: | X-RAY DIFFRACTION (2.72 Å) | | Cite: | Discovery of YJZ5118 : A Potent and Highly Selective Irreversible CDK12/13 Inhibitor with Synergistic Effects in Combination with Akt Inhibition. J.Med.Chem., 68, 2025
|
|
7T61
 
 | | P. aeruginosa LpxA in complex with ligand L15 | | Descriptor: | (3S)-3-({[(Z)-phenylmethylidene]carbamoyl}amino)-N-(1H-tetrazol-5-yl)-1-[3-(trifluoromethyl)benzoyl]-2,3-dihydro-1H-indole-3-carboxamide, ACETATE ION, Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase, ... | | Authors: | Sacco, M, Chen, Y. | | Deposit date: | 2021-12-13 | | Release date: | 2022-07-06 | | Last modified: | 2023-10-18 | | Method: | X-RAY DIFFRACTION (2.1 Å) | | Cite: | Structure-Based Ligand Design Targeting Pseudomonas aeruginosa LpxA in Lipid A Biosynthesis. Acs Infect Dis., 8, 2022
|
|
9CLJ
 
 | |
8VRT
 
 | | The structure of LSD1-CoREST-HDAC1 in complex with KBTBD4R313PRR mutant | | Descriptor: | Histone deacetylase 1, INOSITOL HEXAKISPHOSPHATE, Kelch repeat and BTB domain-containing protein 4, ... | | Authors: | Xie, X, Liau, B, Zheng, N. | | Deposit date: | 2024-01-22 | | Release date: | 2024-11-27 | | Last modified: | 2025-06-11 | | Method: | ELECTRON MICROSCOPY (3.42 Å) | | Cite: | Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations. Nature, 639, 2025
|
|
6G3Y
 
 | | Structure of the mouse 8-oxoguanine DNA Glycosylase mOGG1 in complex with ligand TH5675 | | Descriptor: | 4-(4-azanyl-2-oxidanylidene-3~{H}-benzimidazol-1-yl)-~{N}-(4-iodophenyl)piperidine-1-carboxamide, ACETATE ION, N-glycosylase/DNA lyase, ... | | Authors: | Masuyer, G, Helleday, T, Stenmark, P. | | Deposit date: | 2018-03-26 | | Release date: | 2018-11-28 | | Last modified: | 2024-01-17 | | Method: | X-RAY DIFFRACTION (2.51 Å) | | Cite: | Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation. Science, 362, 2018
|
|